Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations

BACKGROUND: Thyroid carcinomas show a high prevalence of mutations in the oncogene BRAF which are inversely associated with RAS or RET/PTC oncogenic activation. The possibility of using inhibitors on the BRAF pathway as became an interesting therapeutic approach. In thyroid cancer cells the target m...

Descripción completa

Detalles Bibliográficos
Autores principales: Preto, Ana, Gonçalves, Joana, Rebocho, Ana P, Figueiredo, Joana, Meireles, Ana M, Rocha, Ana S, Vasconcelos, Helena M, Seca, Hugo, Seruca, Raquel, Soares, Paula, Sobrinho-Simões, Manuel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776025/
https://www.ncbi.nlm.nih.gov/pubmed/19878585
http://dx.doi.org/10.1186/1471-2407-9-387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776025/
https://www.ncbi.nlm.nih.gov/pubmed/19878585
http://dx.doi.org/10.1186/1471-2407-9-387

Ejemplares similares